129 related articles for article (PubMed ID: 38343115)
1. Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentation.
Goldstein NB; Steel A; Tomb L; Berk Z; Hu J; Balaya V; Hoaglin L; Ganuthula K; Patel M; Mbika E; Robinson WA; Roop DR; Norris DA; Birlea SA
Pigment Cell Melanoma Res; 2024 May; 37(3):378-390. PubMed ID: 38343115
[TBL] [Abstract][Full Text] [Related]
2. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells.
Goldstein NB; Koster MI; Jones KL; Gao B; Hoaglin LG; Robinson SE; Wright MJ; Birlea SI; Luman A; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2018 Mar; 138(3):657-668. PubMed ID: 29054607
[TBL] [Abstract][Full Text] [Related]
3. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling.
Goldstein NB; Steel A; Barbulescu CC; Koster MI; Wright MJ; Jones KL; Gao B; Ward B; Woessner B; Trottier Z; Pakieser J; Hu J; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2021 Mar; 141(3):638-647.e13. PubMed ID: 32800877
[TBL] [Abstract][Full Text] [Related]
4. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
5. Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.
Goldstein NB; Koster MI; Hoaglin LG; Wright MJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
Exp Dermatol; 2016 Oct; 25(10):805-11. PubMed ID: 27193292
[TBL] [Abstract][Full Text] [Related]
6. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
7. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients.
Yang YS; Cho HR; Ryou JH; Lee MH
Int J Dermatol; 2010 Mar; 49(3):317-23. PubMed ID: 20465673
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of melanocyte senescence by the proinflammatory cytokines IFNγ and TNFα impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy.
Dong BQ; Liao ZK; Le Y; Jiang S; Luo LF; Miao F; Le Poole IC; Lei TC
Mech Ageing Dev; 2023 Apr; 211():111779. PubMed ID: 36731753
[TBL] [Abstract][Full Text] [Related]
10. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo.
Kishan Kumar YH; Rao GR; Gopal KV; Shanti G; Rao KV
Indian J Dermatol Venereol Leprol; 2009; 75(2):162-6. PubMed ID: 19293504
[TBL] [Abstract][Full Text] [Related]
12. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
13. Tacalcitol: a useful adjunct to narrow-band ultraviolet-B phototherapy in vitiligo.
Sahu P; Jain VK; Aggarwal K; Kaur S; Dayal S
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):262-268. PubMed ID: 27552149
[TBL] [Abstract][Full Text] [Related]
14. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
[TBL] [Abstract][Full Text] [Related]
15. Reduced Elastin Fibers and Melanocyte Loss in Vitiliginous Skin Are Restored after Repigmentation by Phototherapy and/or Autologous Minigraft Transplantation.
Hirobe T; Enami H
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499690
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of combined intralesional injection of prostaglandin F2α with narrow band UVB phototherapy in treatment of resistant cases of vitiligo.
Eldelee SA; Gheida SF; Sarhan NI; Ibrahim ZA; Elfar NN
J Dermatolog Treat; 2021 Jun; 32(4):383-390. PubMed ID: 31437059
[TBL] [Abstract][Full Text] [Related]
17. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
[No Abstract] [Full Text] [Related]
19. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
Bansal S; Sahoo B; Garg V
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
[TBL] [Abstract][Full Text] [Related]
20. Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo.
Guerra L; Primavera G; Raskovic D; Pellegrini G; Golisano O; Bondanza S; Paterna P; Sonego G; Gobello T; Atzori F; Piazza P; Luci A; De Luca M
Arch Dermatol; 2003 Oct; 139(10):1303-10. PubMed ID: 14568835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
